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Melinda J Carrington1, Garry L Jennings1, Robyn A Clark2 and Simon Stewart1*Abstract
Background: Cardiovascular disease (CVD) is more prevalent in regional and remote Australia compared to
metropolitan areas. The aim of Healthy Hearts was to determine age and sex specific CVD risk factor levels and the
potential value of national risk clinics.
Methods: Healthy Hearts was an observational research study conducted in four purposefully selected higher risk
communities in regional Victoria, Australia. The main outcome measures were the proportion of participants with
CVD risk factors with group comparisons to determine the adjusted likelihood of elevated risk factor levels. Trained
personnel used a standardized protocol over four weeks per community to measure CVD risk factor levels, estimate
absolute CVD risk and provide feedback and advice.
Results: A total of 2125 self-selected participants were assessed (mean age 58± 15 years, 57% women). Overall, CVD
risk factors were highly prevalent. More men than women had≥ 2 modifiable CVD risk factors (76% vs. 68%, p< .001),
pre-existing CVD (20 vs. 15%, p< .01) and a major ECG abnormality requiring follow-up (15% vs. 7%, p< .001) . Less men
reported depressive symptoms compared to women (28% vs. 22%, p< .01). A higher proportion of women were obese
(adjusted OR 1.36, 95% CI 1.13 to 1.63), and physically inactive (adjusted OR 1.32, 95% CI 1.07 to 1.63).
Conclusions: High CVD risk factor levels were confirmed for regional Victoria. Close engagement with individuals and
communities provides scope for the application of regional risk management clinics to reduce the burden of CVD risk
in regional Australia.
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Amid improvements in cardiovascular disease (CVD)
related mortality, risk factors remain high in adult Aus-
tralians. Age-adjusted case fatality rates from CVD have
fallen from 55% of all deaths in the late 1960s to 34% in
2007 [1]. This is attributable to better CVD prevention,
detection and clinical management. Nevertheless, CVD
(notably coronary heart disease) ranks second highest in
healthy years of life lost, representing 16% of the overall
disease burden [1]. Inevitably, the burden of CVD will
inexorably rise within Australia’s ageing population [2].
Despite some encouraging trends in respect to the de-
clining prevalence of major risk factors [1,3], there are
equally cautionary data in respect to sustained, and in
some cases increasing levels of hypertension [4,5],* Correspondence: simon.stewart@bakeridi.edu.au
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distribution, and reproduction in any mediumdyslipidaemia [1,6] and metabolic risk factors (e.g. phys-
ical inactivity/sedentary behavior[1] and obesity [3,7]).
When coupled with increasing longevity, it is therefore
imperative that heart health be improved by mitigating
elevated risk factors [8] through pharmacological and/or
non-pharmacological recommendations embedded
within evidence-based guidelines.
Any focus on reducing cardiovascular risk levels has to
consider higher risk populations. People living in re-
gional, rural or remote locations consistently fare worse
than their metropolitan counterparts [5,9,10] with mor-
tality rates rising in accord with remoteness [1]. Unfor-
tunately, reliable (measured) population data, especially
for biomedical health risk factors, are over 10 years old
and limited in respect to regional data. This extends to
the AusDiab Study and local Crossroads Undiagnosed
Disease Study. Therefore, the overall aim of the Healthy
Hearts Beyond City Limits program was two-fold; firstly
to confirm elevated levels of cardiovascular risk in keytral Ltd. This is an Open Access article distributed under the terms of the
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sex and to simultaneously determine the scope to engage
such communities and individuals to reduce elevated
levels of risk (if confirmed) through regional risk man-
agement clinics.
Methods
Study setting and design
Healthy Hearts was a regional observational research
study. In order to distribute limited resources to areas
that required it most, we used Geographical Informa-
tion System profiling [11] to identify regional areas
with >20,000 total population in Victoria and which
had an increased prevalence of chronic heart failure,
Aboriginal and Torres Strait Islanders, obese children
aged 7–18 years and adults over 65 years of age. Of 10
high risk communities identified, four relatively geo-
graphically dispersed were purposefully selected to visit
(see Figure 1). These included Colac (adult population
of 7,172 [based on place of usual residence] and
152 km South-West of Melbourne), East Gippsland
(11,251 and 294 km North-East of Melbourne),
Geelong (3,664 and 75 km South-West of Melbourne)
and Shepparton (20,410 and 190 km North of
Melbourne).
Co-ordination of the Healthy Hearts program was
facilitated by the local Rotary Clubs in each community.
The program was operational between 0830 and 1700
on all weekdays. We had the capacity for approximately
40 assessments per day, averaging five per hour or
12 minutes per participant. A combination of free heart
health checks via a mobile risk assessment unit were
undertaken in public settings such as a shop or park lo-
cation (73% of all assessments) or via dedicated work-
place visits to key businesses. Assessments were
performed concurrently by a team of at least four Regis-
tered Nurses and fully trained research personnel
according to a standardized protocol. The study was
approved by the Human Research Ethics Committee at
the Alfred Hospital, Melbourne, Australia (Project No.
71/07) and the STROBE guidelines were referred to in
reporting studies of this nature [12].
Participants
We aimed to conduct at least 500 health checks over a
continuous 3–4 weeks of screening per community in
2007–2010. Prior to our arrival, the program was adver-
tised in the local newspaper(s) and radio station and key
businesses were notified. Participants self-selected and
the only inclusion criteria were to be over 18 years of
age with the ability to provide written consent to partici-
pate. Overall, 2,125 participants from the four regional
communities volunteered to have a risk assessment. The
proportion of the adult population assessed (based onplace of usual residence) was 8% in Colac, 5% in East
Gippsland, 14% in Geelong and 3% in Shepparton [13].
Data collection
The program comprised three stages; 1) self-report ques-
tionnaire, 2) non-invasive clinical assessment and, 3) ab-
solute CVD risk assessment report and brief consultative
review. The self-administered questionnaire incorpo-
rated validated assessment instruments and examined
the following: socio-demographic indicators; diet and
lifestyle habits such as smoking (current smoker, ex
smoker or never smoked); fat intake using the MED-
FICTS dietary assessment tool [14]; physical activity via
the International Physical Activity Questionnaire [15];
personal and family medical history; medication use;
mental health via the 2-item Arroll questionnaire [16]
and CES-D [17]; angina and intermittent claudication
symptoms using the Rose Angina questionnaire [18];
and overall health and well-being via the SF-12 [19].
Education was classified as either secondary school or
below or higher than secondary school. Clinical assess-
ments included measurement of blood pressure (BP),
height, weight, anthropometric measurements of ab-
dominal and hip circumference, point of care random
lipid and glucose profiling, electrocardiography (ECG),
spirometry, and in a sub-sample, the ankle brachial pres-
sure index to identify peripheral arterial disease. The
results from many of these variables will be the focus of
a number of future publications. In the final part of par-
ticipation, a summary report describing an individual’s
cardiovascular risk factor profile, 5-year (primary)
[20,21] or 2-year (secondary) [22] absolute CVD risk
score and 5-year type 2 diabetes risk [23] was given to
participants and the details were explained by a senior
member of the Healthy Hearts team (MC, SS or senior
cardiac nurse). During the feedback session, advice and
education was given to address any risk factors; in the
case of an extreme or adverse test result, participants
were advised to consult their general practitioner (GP)
for follow-up or were directed to hospital for more ur-
gent cases.
Instrumentation and procedures
After 5 minutes of rest, BP in the brachial artery was
measured using a validated digital BP monitor (Dina-
mapW PROCARE 300, GE Healthcare, Buckinghamshire,
UK) [24] in the sitting position with an appropriately
sized cuff and table support for the measured arm. The
average of two measurements separated by a one-minute
interval was analyzed provided there were no large varia-
tions in systolic (≥10 mmHg) or diastolic (≥7 mmHg)
BP, in which case another reading was taken and the
closest two readings were analyzed. Height and weight
for assessing body mass index (BMI, kg/m2) were
% aged 55 years % men
1. Colac 
2. East Gippsland 
3. Geelong 
4. Shepparton 
Population* Healthy Hearts Population* Healthy Hearts
47 50 46 48
50 64 46 39
33 74 48 37
33 64 47 46
* based on place of usual residence [13] 
Figure 1 Local government areas identifying four target regional communities of Victoria.
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scales, with the removal of shoes and heavy garments.
Abdominal and hip circumference were measured in the
horizontal plane whilst standing, in accord with the
World Health Organization (WHO) Stepwise approach
to surveillance (STEPS) procedure [25]; the level mid-
way between the lowest rib and iliac crest at the end of a
gentle expiration was taken for abdominal circumference
and the level at the maximum extension of the buttocks
defined hip circumference. Lipid and glucose measure-
ments were analyzed by a validated Cholestech LDXW
System (Cholestech Corporation, CA, USA) [26,27].
Portable PC-based 12-lead ECGs (Universal ECG™) were
collected in adherence with standard electrode place-
ment using Office Medic™ Software (QRS Diagnostic,
MN, USA). Absolute cardiovascular risk for primaryprevention [21] was calculated using age, gender, smok-
ing status, diabetes, systolic BP and total cholesterol
(TC)/high density lipoprotein cholesterol (HDL-C) ratio,
with an adjustment for extremely elevated TC, diastolic
BP, kidney disease and type 2 diabetes [20]. The variables
for secondary prevention were age, gender, diabetes, TC,
HDL-C and for women only, systolic BP and smoking
status[22].
Risk factor definitions
Ideal individualized risk factor targets were based on na-
tional guidelines, reports and validated assessment tools.
Those who currently smoked or had stopped smoking
less than 12 months before the assessment were defined
as a smoker. Energy intake from dietary saturated fat
scores were classified as low (<40), moderate (40–69) or
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than 150 minutes per week of activity [28], with vigorous
intensity activity counted as double time and moderate
intensity or brisk walking counted as single time [1]. Ex-
cess alcohol consumption was defined as >2 standard
drinks on any day [29]. Participants who answered yes to
either of two screening questions for potential depres-
sion [16] proceeded to complete the CES-D whereby de-
pression was indicated by a score of ≥16 [17].
Hypertension was defined as BP≥ 130/80 mmHg for
participants with associated condition(s) or end organ
damage (n= 517), and for all others as BP≥ 140/90 mmHg
[30]. Participants were classified by BMI as normal weight
(< 25 kg/m2), overweight (25 - < 30 kg/m2) or obese
(≥ 30 kg/m2) [31]. For abdominal circumference, normal
weight was classified as <94 cm for men and <80 cm for
women, overweight for measurements between 94 to
<101.9 cm (men) and 80 to <87.9 cm (women), and obese
for measurements ≥102 cm for men and ≥88 cm for
women [1]. For higher risk participants taking lipid-
modifying therapy (n= 395), treatment target levels used
to determine optimal lipid levels were <4 mmol/L for TC,
<2.0 mmol/L for low density lipoprotein cholesterol
(LDL-C) and <1.5 mmol/L for triglycerides [32]. The
recommended target levels for all other participants not
on lipid-modification treatment were 5.5 mmol/L for TC,
3.0 mmol/L for LDL-C and 2.0 mmol/L for triglycerides
[1,7]. For all participants, the target level for HDL-C was
1.0 mmol/L [32] and <6.9 or <11.0 mmol/L for fasting and
random glucose levels, respectively [33]. Dyslipidaemia
was defined as not meeting any one of the lipid target
levels just described. Metabolic syndrome was defined by
abdominal obesity in the presence of any of two, including
treatment for, the following deficiencies: raised levels of
triglycerides, BP, fasting glucose (where applicable) or
reduced HDL-C [34]. Absolute primary and secondary
CVD risk was classified as low (≤9%), moderate (10-15%)
or high (≥16%), defaulting those with extremely elevated
TC or BP, kidney disease, or type 2 diabetes at >60 years
of age to high risk (primary prevention risk scores only)
[20]. All ECGs were systematically scored by a trained
cardiac nurse using the Minnesota Code [35] and con-
firmed by SS.
Data analyses
Data were analyzed using SPSS Statistics 19.0. Normally
distributed continuous data are presented as the mean ±
standard deviation and non-Gaussian distributed vari-
ables as the median plus interquartile range. Categorical
data are presented as percentages. Discrete variables
were analyzed via odds ratios (OR) with 95% confidence
intervals (CI) or χ2 analysis. Students t-tests were used
for continuous variables with consideration to Levene’s
Test for Equality of Variances to correct for anyviolations of the assumption of homogeneity of variance.
Multiple logistic regression analyses (entry model) were
performed on age, sex, community, education and
potential depression to derive adjusted ORs for the like-
lihood estimates of CVD risk factors. Significance was
accepted at the two-sided level of 0.05.
Results
Study cohort
able 1 summarizes the socio-demographic and clinical
risk factor profiles according to sex. There were more
women (1218, 57%) than men who were of a similar age
and both sexes comprised mostly people from a Cauca-
sian/European ethnic background (96%; OR 0.88, 95%
CI 0.58-1.32). More men than women were married/liv-
ing with a partner (OR 1.92, 95% CI 1.56-2.36) whilst
less men had received maximum secondary school edu-
cation (OR 0.59, 95% CI 0.49-0.70). More than half were
currently employed unskilled workers and one quarter
were employed in a professional role with more male
technical/trades people and more unskilled female
workers.
Overall, CVD risk factors were highly prevalent
(Table 2). Regardless of gender, approximately two
thirds of participants had elevated TC or LDL-C, 59%
hypertension and 28% obesity by BMI. A total of 29%
were physically inactive, 6% had diabetes/hypergly-
caemia, 21% reported increased alcohol consumption,
11% were smokers and 25% had potential depression.
Figure 2 highlights the proportion of men and women
by age group who were assessed with a cardiovascular
risk factor(s). The three most prevalent risks were
elevated LDL-C, hypertension and obesity. Older
adults (aged ≥ 55 years) had more elevated LDL-C,
hypertension, obesity (either by BMI or waist circum-
ference) and diabetes, whereas a greater proportion of
younger adults (aged 18 to 54 years) were smokers
and reported increased alcohol consumption and de-
pression. A similar proportion of older and younger
adult men and women were physically inactive.
Sex-based differences
Table 1 shows that there were no sex-based differ-
ences in the proportion of current smokers (OR 1.15,
95% CI 0.87-1.52), LDL-C levels (p > .05) or type 2
diabetes/hyperglycaemia (OR 1.28, 95% CI 0.89-1.85).
On average, men had 7 mmHg and 6 mmHg higher
systolic and diastolic BP (both p < .001) and were bor-
derline hypertensive. Men were more overweight
according to BMI with 75% classified as either over-
weight or obese compared to 65% of women (data
not shown) and had significantly higher glucose
levels, consumed over twice the number of standard
drinks of alcohol/week and were more physically
Table 1 Socio-demographic and risk profile of participants
All n = 2125 Men n=907 (43%) Women n=1218 (57%) OR [95% CI] p value
Socio-demographic profile
Age (years) 57.6 ± 14.6 57.2 ± 15.2 58.0 ± 14.2 .209
Male gender 907 (43%) 907 (100%) —
Caucasian ethnicity 2030 (96%) 863 (95%) 1167 (96%) 0.88 [0.58-1.32] .523
Married / living with partner 1566 (74%) 727 (81%) 839 (69%) 1.92 [1.56-2.36] <.001
Secondary school highest education 1203 (59%) 452 (38%) 751 (62%) 0.59 [0.49-0.70] <.001
Current occupation:
Professionals/Semi-professionals 251 (25%) 123 (26%) 128 (25%) <.001
Technical/Tradespeople 191 (19%) 137 (29%) 54 (10%)
Unskilled workers 559 (56%) 220 (46%) 339 (65%)
Risk factor profile
Current smoking 227 (11%) 104 (12%) 123 (10%) 1.15 [0.87-1.52] .313
Systolic blood pressure (mmHg) 137 ± 21 141 ± 19 134± 22 <.001
Diastolic blood pressure (mmHg) 75 ± 11 79 ± 10 73 ± 10 <.001
Body mass index (kg/m2) 27.7 ± 5.1 28.0 ± 4.5 27.5 ± 5.5 .035
Total cholesterol (mmol/L) 5.21 ± 1.13 5.14 ± 1.17 5.26 ± 1.10 .013
LDL-C (mmol/L) 2.98 ± 1.02 3.02 ± 1.04 2.96 ± 1.00 .175
HDL-C (mmol/L) 1.34 ± 0.43 1.16 ± 0.38 1.47 ± 0.42 <.001
TC/HDL ratio (mmol/L) 4.22 ± 1.70 4.77 ± 1.89 3.81 ± 1.42 <.001
Glucose (mmol/L) 5.80 ± 1.53 6.02 ± 1.72 5.64 ± 1.36 <.001
Alcohol consumption (drinks per week) 4.3 ± 7.8 6.51 ± 10.28 2.85 ± 5.02 <.001
Physical activity (MET-minutes per week) 998 [446–2083] 1118 [518–2611] 924 [396–1817] <.001
Absolute COD risk (%)
Primary 8 ± 6 12 ± 7 6± 4 <.001
Secondary 6 ± 4 9 ± 2 3± 2 <.001
≥ 2 modifiable risk factors 1508 (71%) 686 (76%) 822 (68%) 1.50 [1.23-1.81] <.001
Family history of CVD 673 (32%) 266 (29%) 407 (33%) 0.83 [0.69-1.00] .045
Pre-existing CVD 360 (17%) 178 (20%) 182 (15%) 1.39 [1.11-1.75] .004
Type 2 diabetes/hyperglycaemia 124 (6%) 60 (7%) 64 (5%) 1.28 [0.89-1.85] .178
Potential depression 514 (25%) 190 (22%) 324 (28%) 0.72 [0.59-0.89] .002
Major ECG abnormality 209 (11%) 129 (15%) 80 (7%) 2.35 [1.75-3.16] <.001
LDL-C: low density lipoprotein; HDL-C: high density lipoprotein; MET: metabolic equivalent of task; CVD: cardiovascular disease; mmHg: millimeters of mercury;
mmol/L: millimols per liter.
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TC levels but also higher HDL-C levels and a lower
TC to HDL-C ratio (denoting reduced risk). Average
CVD risk scores were twice and three times as high
in men for primary and secondary prevention, re-
spectively. More men than women had ≥2 modifiable
risk factors (OR 1.50 95% CI 1.23-1.81) and a prior
history of the same (OR 1.39, 95% CI 1.11-1.75).
Alternatively, less men reported depressive symptoms
(OR 0.72, 95% CI 0.59-0.89). Of those who had an
ECG as part of their assessment (1951, 92%), 209
(11%) participants had a potentially significantabnormality with two-fold more GP referrals in men
(OR 2.35, 95% CI 1.75 to 3.16).
Regional comparisons
Table 2 indicates the (unadjusted) number of partici-
pants with risk factors according to sex and region.
More women (approximately two thirds) from East
Gippsland and Geelong participated compared to the
other two communities which had a greater gender bal-
ance. The age profile of men and women was similar
across all communities. There were also similarities be-
tween men and women in smoking status and type 2
Table 2 Proportion of participants with risk factors according to sex and region
Colac East Gippsland Geelong Shepparton All
n = 548 (26%) n= 552 (26%) n= 520 (24%) n =505 (24%)
Men Women Men Women Men Women Men Women
n=265 n=283 n=218 n=334 n=191 n=329 n=233 n=272
Socio-demographic risk factors:
Aged over 55 years 123 (46%) 149 (53%) 146 (67%) 207 (62%) 144 (75%) 241 (73%) 144 (62%) 178 (65%) 1,332 (63%)
Male gender (% of total cohort) 265 (48%) 218 (40%) 191 (37%) 233 (46%) 907 (43%)
Risk factor profile:
Current smoking 38 (14%) 27 (10%) 25 (12%) 39 (12%) 11 (6%) 23 (7%) 30 (13%) 34 (13%) 227 (11%)
Hypertension 179 (68%) 158 (56%) 155 (71%) 178 (53%) 113 (59%) 149 (45%) 161 (69%) 157 (58%) 1,250 (59%)
Obese (BMI) 59 (22%) 71 (25%) 49 (23%) 90 (27%) 37 (19%) 84 (26%) 109 (47%) 96 (35%) 595 (28%)
Abdominal obesity 92 (35%) 118 (42%) 69 (32%) 173 (52%) 68 (36%) 170 (52%) 125 (54%) 137 (51%) 952 (45%)
Elevated total cholesterol 199 (76%) 192 (69%) 147 (71%) 210 (65%) 111 (58%) 194 (59%) 148 (64%) 157 (58%) 1,358 (65%)
Elevated LDL cholesterol 194 (85%) 190 (72%) 143 (75%) 191 (65%) 119 (67%) 189 (61%) 129 (63%) 147 (57%) 1,302 (67%)
Reduced HDL cholesterol 86 (34%) 33 (12%) 60 (29%) 36 (11%) 80 (43%) 39 (12%) 75 (33%) 27 (10%) 436 (21%)
Metabolic syndrome 113 (43%) 97 (34%) 93 (43%) 133 (40%) 85 (45%) 130 (40%) 135 (58%) 114 (42%) 900 (42%)
Increased alcohol consumption — — 66 (30%) 56 (17%) 46 (24%) 29 (9%) 91 (39%) 41 (15%) 329 (21%)
Physical inactivity 66 (27%) 91 (35%) 34 (17%) 99 (33%) 45 (25%) 82 (26%) 60 (29%) 83 (34%) 560 (29%)
Absolute CVD risk (primary & secondary):
Low risk 65 (44%) 136 (84%) 68 (46%) 195 (85%) 62 (48%) 209 (89%) 74 (49%) 158 (86%) 967 (70%)
Moderate risk 49 (33%) 19 (12%) 48 (33%) 28 (12%) 46 (36%) 24 (10%) 47 (31%) 22 (12%) 283 (20%)
High risk 34 (23%) 7 (4%) 31 (21%) 6 (3%) 21 (16%) 1 (1%) 31 (20%) 4 (2%) 135 (10%)
≥ 2 modifiable risk factors 202 (76%) 194 (69%) 164 (75%) 233 (70%) 132 (69%) 201 (61%) 188 (81%) 194 (71%) 1,508 (71%)
Family history of CVD 55 (21%) 68 (24%) 49 (23%) 103 (31%) 75 (39%) 125 (38%) 87 (37%) 111 (41%) 673 (32%)
Pre-existing CVD 49 (19%) 47 (17%) 52 (24%) 46 (14%) 31 (16%) 41 (13%) 46 (20%) 48 (18%) 360 (17%)
Type 2 diabetes/hyperglycaemia 18 (7%) 13 (5%) 13 (6%) 20 (6%) 11 (6%) 11 (3%) 18 (8%) 20 (7%) 124 (6%)
Potential depression 42 (16%) 56 (21%) 30 (14%) 83 (26%) 45 (24%) 108 (34%) 73 (33%) 77 (30%) 514 (25%)
LDL cholesterol calculated for 1,930 participants, physical inactivity available for 1,949 and absolute CVD risk estimated for 1,385 cases.
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in Geelong presented with the latter). The proportion of
men in all communities with hypertension, elevated TC
and LDL-C, reduced HDL-C and increased alcohol con-
sumption was greater than women. Typically, more
women were physically inactive and indicated a positive
family history of CVD. Excepting Shepparton, more
women were obese according to both BMI and abdom-
inal circumference and reported depressive symptoms.
Overall, more men than women were determined to
have the metabolic syndrome, ≥2 modifiable risk factors,
pre-existing CVD or higher estimated absolute CVD risk
levels in the moderate (33% vs. 11%) and high risk cat-
egories (20% vs. 2%).
Correlates of elevated risk
The multiple logistic regression models that we specified
correctly predicted between 58% and 84% of individuals
with CVD risk factors. On an adjusted basis, the odds for
CVD risk were lower in women than men, ranging froman OR 0.31 (95% CI 0.24 to 0.42) for increased alcohol
consumption to OR 0.82 (95% CI 0.67 to 1.0) for elevated
TC. Conversely, women were more likely to be obese (OR
1.36, 95% CI 1.13 to 1.63) and physically inactive (OR
1.32, 95% CI 1.07 to 1.63). For each additional year of age,
the odds significantly increased from a range of 2% (for
LDL-C) to 7% (for hypertension) [95% CI range 1.01-1.06
to 1.02-1.08] but decreased by 4% (95% CI 0.95 to 0.97)
for increased alcohol consumption. Lower education level
was associated with greater CVD risk (adjusted OR range
1.25 to 1.55, 95% CI range 1.02-1.28 to 1.53-1.88). Gener-
ally, the odds for CVD risk factors were significantly lower
for Geelong residents compared to Colac (adjusted OR
range 0.37 to 0.56, 95% CI range 0.27-0.39 to 0.49-0.80)
and for those without depressive symptoms (adjusted OR
range 0.68 to 0.80, 95% CI range 0.50-0.64 to 0.92-0.98).
Shepparton residents were more likely to be obese
(adjusted OR 1.70, 95% CI 1.31 to 2.21) and have
increased alcohol consumption compared to Geelong resi-
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Figure 2 Proportion of participants with elevated risk factors according to sex and age.
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The Healthy Hearts Beyond City Limits program, in-
volving over 2,000 adults from four diverse regional
locations, is the largest surveillance study of CVD-
related risk factors and associated lifestyle and health
behaviors utilizing measured results in regional Victoria,
Australia. Overall, high levels of risk factors for CVD
were common in all age groups. The proportion of par-
ticipants outside individualized recommended levels
ranged from 68% for elevated LDL-C to 11% for smok-
ing, with abnormal cholesterol levels, raised BP and
excess weight affecting half of participants. Younger
adults more frequently reported smoking and increased
alcohol consumption as well as depressive symptoms,
the latter being more evident in women from most
regional communities. Independent of regional loca-
tion, men lagged behind women in many CVD risk
indicators. Alternatively, more women were obese andphysically inactive. Inter-community differences were
evident with participants from the larger community
and surrounding areas of Geelong having more favor-
able risk profiles compared to Colac who had the
worst, yet those living in Shepparton were more obese
and had excess alcohol consumption. High levels of
risk confirmed a persistent problem in these communi-
ties. Alternatively, high levels of engagement reaffirmed
the potential value of an extended program combining
surveillance and active prevention.
The unadjusted prevalence of elevated BP, TC and
LDL-C observed in this cohort was substantially higher
than previous reports [9,10,36,37] but probably reflects
participant self-selection and application of individua-
lized (treatment) targets. Our older study cohort may
partially, although not completely, explain the higher
proportion of hypertension found in the rural Greater
Green Triangle Risk Factor Study [37]. Alternatively, it
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of (representative) population data, it is difficult to
truly quantify the problem of elevated BP in regional
Victorians. The (predominantly urban) AusDiab study
found a lower prevalence of elevated TC [9] based on
a cut-off of 5.5 mmol/L, but in the absence of regional
differentials, there are no recent population data to
compare our findings to assess whether they parallel
national declining trends in primary care [6] and in-
deed global patterns [38]. Equally concerning were the
high rates of overweight and obesity, a trend now seen
world-wide [39]. Compared to contemporary regional
estimates (78% for men and 52% for women) [3], our
findings were slightly lower for men yet higher for
women and generally overestimated compared to state
statistics [10]. However, other studies have relied upon
self-reported and therefore underestimated BMI [40].
Of concern, one in four adults reported depression.
This appeared higher than the latest population esti-
mates but confirmed that women were more likely
affected than men [9]. In the latest National Health
Survey, regional Australians were 16% more likely to
report a mental health problem [41].
Despite highly prevalent CVD risk factors, absolute
CVD risk scores were not congruently elevated empha-
sizing the well known limitation of risk classification for
“low risk” who demonstrate coronary atherosclerosis
[42]. Unfortunately, the introduction of new biomarkers
[43] and non-invasive tests [42] are yet to improve the
predictive ability of risk equations in asymptomatic indi-
viduals from a practical perspective. The end point of
what to predict (e.g. CVD or coronary heart disease) also
remains vague [42] yet Australian guidelines advocate for
a composite CVD risk score [20] to identify individuals
who may benefit from preventative therapy. All partici-
pants in the Healthy Hearts program, regardless of abso-
lute CVD risk levels, were counseled on recommended
risk factors levels and ideal diet and lifestyle behaviors or
pharmacological treatment (if necessary). Exploring indi-
viduals’ present risk factors and future CVD risk was
highly engaging with strong potential for significant risk
reduction at earlier stages across the spectrum of CVD.
An individual’s risk of illness cannot be considered in
isolation from their wider community. We observed het-
erogeneity in respect to the risk profiles of individuals in
the different communities. This undoubtedly reflects the
differentials of the socio-demographic profiles of partici-
pants but also reflects the differences in the characteris-
tics of the broader communities in which these
individuals lived. This includes the size, geographic loca-
tion and level of local health care services. At the indi-
vidual level, older communities will likely have elevated
BP levels, and places with reduced access to a healthier
and cheaper food supply might have higher levels ofmetabolic disturbances. As such there is likely to be con-
siderable heterogeneity in the specific risk profile and
health care needs of regional communities, requiring
adaptation of services at their local level. Overall, Aus-
tralia’s ageing population has resulted in significant re-
tirement migration from urban to regional areas.
Simultaneously, the closure or down-grading of local
hospitals to aged care centers has created a mismatch
between the supply and demand for regional health care
services. Specialist cardiac services are scarce and few
cardiologists practice in non-metropolitan areas [41].
The burden of health care is predominantly transferred
to regional primary care services [41] where there are 87
full time equivalent GPs/100,000 population compared
to 98 in major cities [44]. Financially stimulated growth
in regional GP numbers has been offset by reduced op-
erational hours [44]. Ominously, regional Australians are
more likely to die from ischaemic heart disease (44%) or
stroke (31%) than those living in major cities [41] with
even worse differentials for fatal hypertensive heart dis-
ease (90% more likely) and heart failure (70%) events.
These data underlie the potential value of regional risk
clinics to support already stressed primary care services.
Encouragingly, the degree of individual and community
engagement in the Healthy Hearts program exceeded
expectations. Participating individuals overcame barriers
to limited access to health care that is typical of regional
community life and this program provides the impetus
to establish cost-effective community-based risk man-
agement clinics. This was the focus of the soon to be
reported Protecting Healthy Hearts program undertaken
in regional Victoria, Australia.
There are a number of important limitations which
may influence the interpretation and generalizability
of our findings. Given limited resources we selected
higher risk communities and participants were self-
selected resulting in age and gender differences com-
pared to population estimates in some communities
(refer Figure 1). Self-selection potentially introduced
further bias towards those with higher levels of risk, al-
beit the proportion of smokers (11%) we found was
reduced compared to national population surveys (18%)
[1], possibly due to our older cohort and the trend of
decreased smoking prevalence with age. We measured
lipid profiles in the non-fasting state in many partici-
pants (93%) based on findings that levels of TC, LDL-C,
HDL-C, TC to HDL-C ratio and triglycerides are min-
imally affected by normal food intake in individuals in
the general population [45]. It is also unlikely that the
lipid profile response to typical food intake would vary
according to sample timing. We cannot discount sea-
sonal weather confounders and extraneous factors such
as drought and floods which might particularly affect
farmers.
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In summary, the Healthy Hearts program confirmed a
high proportion of individuals with elevated CVD-
related risk factors seeking to better understand their
heart health. These data suggest that more needs to be
done for regional Australian adults to address inequit-
able rates (short to longer term) of CVD relative to their
metropolitan counterparts. The overwhelming positive
response towards the Healthy Hearts program shows
there is scope to engage communities and individuals to
reduce elevated levels of risk and underlies the potential
value of risk management clinics and nurse-led interven-
tion programs in regional areas.
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